Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;16(11):979-86.
doi: 10.1111/hpb.12264. Epub 2014 Apr 18.

Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study

Collaborators, Affiliations

Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study

Umberto Cillo et al. HPB (Oxford). 2014 Nov.

Abstract

Objectives: There are no prospective studies of laparoscopic microwave (MW) ablation in patients with hepatocellular carcinoma (HCC). The aim of this study was to demonstrate the safety and efficacy of laparoscopic MW ablation.

Methods: A prospective study group of consecutive HCC patients considered ineligible for liver resection and/or percutaneous ablation was conducted from December 2009 to December 2010. Short-term (3-month) outcomes included a centralized revision of radiological response, mortality and morbidity. Mid-term (24-month) outcomes included time to recurrence in the study group compared with that in a cohort of consecutive patients treated with laparoscopic radiofrequency (RF) ablation using propensity score analysis.

Results: A total of 42 patients were enrolled. Their median age was 64 years; 67% were positive for hepatitis C virus; 33% were of Child-Pugh class B status; the median tumour diameter was 2.5 cm, and 48% of patients had multinodular HCC. In 47 of 50 (94%) nodules treated with MW ablation, a complete radiological response was observed at 3 months. There was no perioperative mortality. The overall morbidity rate was 24%. The 2-year survival rate was 79% and the 2-year recurrence rate was 55%. Using propensity score analysis (in 28 MW ablation patients and 28 RF ablation controls), 2-year recurrence rates were 55% in the MW ablation group and 77% in the control group (P = 0.03).

Conclusions: Laparoscopic MW ablation is a safe and effective therapeutic option for selected HCC patients who are ineligible for liver resection and/or percutaneous ablation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan–Meier curves showing survival in unmatched cohorts of hepatocellular carcinoma patients submitted to laparoscopic microwave (MW) or radiofrequency (RF) ablation (log-rank test, P = 0.0089)
Figure 2
Figure 2
Kaplan–Meier curves showing recurrence in unmatched cohorts of hepatocellular carcinoma patients submitted to laparoscopic microwave (MW) or radiofrequency (RF) ablation (log-rank test, P = 0.0162)
Figure 3
Figure 3
Kaplan–Meier curves showing survival in propensity score-matched cohorts of hepatocellular carcinoma patients submitted to laparoscopic microwave (MW) or radiofrequency (RF) ablation (log-rank test, P = 0.2056)
Figure 4
Figure 4
Kaplan–Meier curves showing recurrence in propensity score-matched cohorts of hepatocellular carcinoma patients submitted to laparoscopic microwave (MW) or radiofrequency (RF) ablation (log-rank test, P = 0.0354)

References

    1. Sherman M. Epidemiology of hepatocellular carcinoma. Oncology. 2010;78(Suppl. 1):7–10. - PubMed
    1. Poon RT-P, Fan S-T, Tsang FH-F, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg. 2002;235:466–486. - PMC - PubMed
    1. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western centre. Ann Surg. 1999;229:790–799. ; discussion 799–800. - PMC - PubMed
    1. Kawamoto C, Ido K, Isoda N, Hozumi M, Nagamine N, Ono K, et al. Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation. Cancer. 2005;103:985–993. - PubMed
    1. Sakaguchi H, Seki S, Tsuji K, Teramoto K, Suzuki M, Kioka K, et al. Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-centre study. Hepatol Res. 2009;39:47–52. - PubMed

MeSH terms